logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9616053 B1

PDFFull Text
Date of Patent:
Apr. 11, 2017

Filed:

Dec. 16, 2015

Indolin-2-one or pyrrolo-pyridin/pyrimidin-2-one derivatives

Applicant:

Hoffmann-la Roche Inc., Little Falls, NJ (US);

Inventors:

Daniela Brunner, Riverdale, NY (US);

Hans Hilpert, Muenchenstein, CH;

Sabine Kolczewski, Loerrach, DE;

Anja Limberg, Basel, CH;

Jessica Malberg, Dobbs Ferry, NY (US);

Eric Prinssen, Guebwiller, FR;

Claus Riemer, Freiburg, DE;

Bavani G. Shankar, Nanuet, NY (US);

Theodor Stoll, Binningen, CH;

Assignee:

Hoffmann-La Roche Inc., Little Falls, NJ (US);

Attorney:
Primary Examiner:

Brian McDowell

Int. Cl.
CPC ...
A61K 31/404 (2006.01); C07D 401/04 (2006.01); C07D 403/04 (2006.01); C07D 403/14 (2006.01); A61K 31/4439 (2006.01); C07D 405/14 (2006.01); C07D 413/14 (2006.01); C07D 413/04 (2006.01); C07H 19/044 (2006.01); C07D 417/04 (2006.01); C07D 471/04 (2006.01); C07D 487/04 (2006.01); C07D 498/04 (2006.01); A61K 31/19 (2006.01); A61K 31/4178 (2006.01); A61K 31/422 (2006.01); A61K 31/4245 (2006.01); A61K 31/433 (2006.01); A61K 31/437 (2006.01); A61K 31/438 (2006.01); A61K 31/496 (2006.01); A61K 31/497 (2006.01); A61K 31/501 (2006.01); A61K 31/506 (2006.01); A61K 31/519 (2006.01); A61K 31/5377 (2006.01); A61K 31/5383 (2006.01); A61K 31/55 (2006.01); A61K 31/7064 (2006.01); A61K 45/06 (2006.01); C07C 53/06 (2006.01); C07D 471/10 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4439 (2013.01); A61K 31/19 (2013.01); A61K 31/4178 (2013.01); A61K 31/422 (2013.01); A61K 31/4245 (2013.01); A61K 31/433 (2013.01); A61K 31/437 (2013.01); A61K 31/438 (2013.01); A61K 31/496 (2013.01); A61K 31/497 (2013.01); A61K 31/501 (2013.01); A61K 31/506 (2013.01); A61K 31/519 (2013.01); A61K 31/5377 (2013.01); A61K 31/5383 (2013.01); A61K 31/55 (2013.01); A61K 31/7064 (2013.01); A61K 45/06 (2013.01); C07C 53/06 (2013.01); C07D 401/04 (2013.01); C07D 403/04 (2013.01); C07D 403/14 (2013.01); C07D 405/14 (2013.01); C07D 413/04 (2013.01); C07D 413/14 (2013.01); C07D 417/04 (2013.01); C07D 471/04 (2013.01); C07D 471/10 (2013.01); C07D 487/04 (2013.01); C07D 498/04 (2013.01); C07H 19/044 (2013.01);
Abstract

The present invention is concerned with 2-oxo-2,3-dihydro-indoles of general formula (I) wherein Ar, X, X, R, R, R, m, n and the dotted line are as defined herein which compounds are useful for treating certain central nervous system disorders as described herein.

Find Patent Forward Citations

Brunner, Daniela. (2017). Indolin-2-one or pyrrolo-pyridin/pyrimidin-2-one derivatives (U.S. Patent No. 9616053). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9616053

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…